![Sphere that has the top right fourth removed (exposed) Colors from left are orange, dark blue with orange dots, light blue with horizontal lines, then black. Inside the exposure is green and black with boxes.](/sites/default/files/styles/featured_square_large/public/2024-06/slicer.jpg?h=56311bf6&itok=bCZz09pJ)
Filter News
Area of Research
- (-) Biology and Environment (19)
- (-) Neutron Science (7)
- Clean Energy (28)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (2)
- Isotopes (2)
- Materials (13)
- Materials for Computing (1)
- National Security (16)
- Nuclear Science and Technology (2)
- Quantum information Science (2)
- Supercomputing (44)
News Topics
- (-) Artificial Intelligence (8)
- (-) Coronavirus (7)
- (-) Mathematics (3)
- (-) Microscopy (8)
- (-) Space Exploration (1)
- (-) Summit (8)
- 3-D Printing/Advanced Manufacturing (5)
- Big Data (7)
- Bioenergy (28)
- Biology (43)
- Biomedical (13)
- Biotechnology (6)
- Chemical Sciences (4)
- Clean Water (10)
- Climate Change (23)
- Composites (1)
- Computer Science (17)
- Decarbonization (16)
- Energy Storage (4)
- Environment (60)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (3)
- High-Performance Computing (13)
- Hydropower (5)
- Machine Learning (7)
- Materials (6)
- Materials Science (9)
- Mercury (6)
- Nanotechnology (4)
- National Security (3)
- Net Zero (1)
- Neutron Science (33)
- Nuclear Energy (1)
- Physics (2)
- Polymers (2)
- Quantum Computing (1)
- Quantum Science (1)
- Renewable Energy (1)
- Security (2)
- Simulation (9)
- Sustainable Energy (17)
- Transportation (1)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![ORNL researchers are leading virtual STEM outreach activities, such as an Internet of Things demonstration in which participants in ORCSGirls control an LED board remotely.](/sites/default/files/styles/list_page_thumbnail/public/2020-06/200411_ogi_0055_0.jpg?h=28121b77&itok=ucPjaIJO)
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
![Omar Demerdash](/sites/default/files/styles/list_page_thumbnail/public/2020-05/demerdash_crop.jpg?h=8831409f&itok=2J2gUqDr)
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
![Coronavirus graphic](/sites/default/files/styles/list_page_thumbnail/public/2020-04/covid19_jh_0.png?h=d1cb525d&itok=PyngFUZw)
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.